🇺🇸 FDA
Patent

US 11098010

Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

granted A61KA61K31/16A61K31/167

Quick answer

US patent 11098010 (Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/16, A61K31/167, A61K31/18, A61K31/27